Where $5M–$10M Seed Rounds Are Clustering: Proptech, Cancer Biotech, Space and Robotics

Proptech, Cancer Biotech, Space and Robotics Lead $5M–$10M Seed Rounds

Seed-stage investors are putting midsize rounds of $5 million to $10 million into a narrower set of industries than the broader startup market might suggest. A Crunchbase News analysis of roughly 800 global seed financings closed this year found money clustering in cybersecurity, proptech, cancer therapeutics, space tech and robotics. The report focused on that range deliberately, arguing it is a truer test of classic seed behavior than the megarounds that dominate headlines.

Proptech offers the clearest example of a large market drawing modest bets. Citing a McKinsey estimate that real estate accounts for about two-thirds of global net worth, the report notes that proptech investment last year totaled just over $10 billion, well below earlier peaks. The funded companies in the $5M–$10M range include Hint, an AI-powered home management system; Optiml, which develops real estate decarbonization software; and Krane, an AI-enabled construction supply chain platform.

Cancer therapeutics was the second theme, driven by the scale of the disease: roughly 39% of Americans are expected to receive a cancer diagnosis in their lifetime, and cancer is the second-leading cause of death. Three California startups raised $10 million each, the largest rounds in the sample: Rybodyn, working on AI-driven discovery of undetected cancer targets; Vivere Oncotherapies, a targeted solid-tumor therapy developer; and Valius Sciences, focused on cancer diagnostics.

In space tech, the report notes the sector's most visible event this year was SpaceX's IPO, but seed deals continued quietly underneath it. Lux Aeterna raised the largest round in the target range for reusable satellites, followed by InSpacePropulsion Technologies and Constellation Space, which builds an ML-native operations platform for satellite fleets. Robotics produced the most geographically diverse list, spanning Asia, North America, Europe and Australia, with examples such as Somnia Lab, Bubble Robotics and greenhouse-harvesting robot maker Eternal.ag.

What the Round Sizes Reveal About Seed Investor Risk Appetite

The dataset is a snapshot, but it says something about how seed investors are positioning: the $5M–$10M range lets them back ambitious teams without demanding megaround-scale evidence of traction. The clustering also suggests capital is following problems with obvious scale — real estate's share of global wealth, cancer's mortality burden, satellite infrastructure needs — rather than untested categories.

The Signal in the Size Range

A round of $5 million to $10 million is large enough to build a product and hire a core team, but too small to carry a company for years. That combination is why the sector mix matters: investors are effectively funding thesis bets that will need follow-on capital. The interpretation here is that the range favours sectors where a modest team can demonstrate meaningful progress, which helps explain the presence of software-led proptech and AI-driven diagnostics alongside hardware-heavy space and robotics ventures.

Proptech: A Headroom Argument

McKinsey's estimate that real estate is roughly two-thirds of global net worth is the backdrop for the proptech cluster. Crunchbase's own figure of just over $10 billion in proptech investment last year, far below prior peaks, is the counterweight: the sector is large but funding has been cyclical. Seed investors are betting on efficiency, decarbonization and construction supply chains — all areas where cost pressure on building owners and developers creates a plausible buyer base.

Cancer Therapeutics: Long Timelines, Modest Tickets

The three $10 million seed rounds for Rybodyn, Vivere Oncotherapies and Valius Sciences show investors willing to enter drug and diagnostics development early. That is a risky position because clinical and regulatory milestones usually require substantially more capital than a seed round can provide. The analytical point is that these bets are less about near-term revenue and more about securing a position before larger rounds set higher valuations.

Space and Robotics: Global, Infrastructure-Led

SpaceX's IPO has raised the sector's profile, but the seed data shows a parallel market in reusable satellites, propulsion and fleet operations software. Robotics was the standout for geographic spread, with an 18-company sample across four continents. The implication is that these are global, capital-hungry niches where differentiation — in greenhouse harvesting, underwater robots or intimacy robots — matters as much as the sector label.

Using the Crunchbase Data: Next Steps for Founders and Investors

For founders and seed investors, the Crunchbase roundup offers a practical map of where mid-sized seed capital is flowing in 2026.

• Proptech founders should pitch the same use cases that are clearing the bar this year: decarbonization software (Optiml), AI construction supply chains (Krane) and AI home management (Hint), backed by the gap between real estate's roughly two-thirds share of global net worth and last year's $10B-plus proptech investment.
• Seed investors examining cancer-therapeutics deals should assume the $10M tickets seen at Rybodyn, Vivere Oncotherapies and Valius Sciences are entry bets, not full-build financing, and underwrite the timing of the next round.
• Space tech startups should expect a crowded field: Lux Aeterna led the target range with reusable satellites, while InSpacePropulsion Technologies and Constellation Space are active in adjacent niches, making follow-on capital contested.
• Robotics founders should plan for global competition — the report's 18-company sample spans Asia, North America, Europe and Australia — and differentiate by application, as Eternal.ag, Bubble Robotics and Somnia Lab each do.